Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Critical earnings dates you can't miss
See Calendar
Close

Merck & Company Inc (MRK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,535.00 -11.00    -0.71%
- Closed. Currency in MXN
Type:  Equity
Market:  Mexico
ISIN:  US58933Y1055 
S/N:  58933Y105
  • Volume: 118
  • Bid/Ask: 1,527.11 / 1,582.00
  • Day's Range: 1,535.00 - 1,550.00
Merck&Co 1,535.00 -11.00 -0.71%

Merck & Company Inc Company Profile

 
Get an in-depth profile of Merck & Company Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

74000

Equity Type

ORD

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Contact Information

Address 126 East Lincoln Avenue
Rahway, 07065
United States
Phone 908 740 4000
Fax -

Top Executives

Name Age Since Title
Patricia F. Russo 70 1995 Independent Director
Thomas Henry Glocer 63 2007 Independent Lead Director
Pamela J. Craig 65 2015 Independent Director
Robert M. Davis 55 2014 CEO & Chairman
Paul B. Rothman 66 2015 Independent Director
Inge G. Thulin 70 2018 Independent Director
Mary Ellen Coe 56 2019 Independent Director
Kathy J. Warden 52 2020 Independent Director
Risa J. Lavizzo-Mourey 69 2020 Independent Director
Douglas M. Baker 65 2022 Independent Director
Christine E. Seidman 71 2020 Independent Director
Stephen L. Mayo 62 2021 Independent Director
Surendralal Lanca Karsanbhai 55 2025 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRK Comments

Write your thoughts about Merck & Company Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
SomeOne LikeYou
SomeOne LikeYou Jul 13, 2025 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The fair value of Merck & Company Inc (MRK) is $138.08. The current price ($83.36) indicates stock is undervalued by 65.64%. The Suggested Sell Price is $179.5.
Péter Dovák
Péter Dovák Jun 10, 2025 12:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
here you find value
Satisfaction Guaranteed
Satisfaction Guaranteed May 20, 2025 7:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Investing.com is now saying the stock should be valued as $112. Why the sudden changed from $56.93?
Tsai Eric
Tsai Eric May 15, 2025 11:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good buy with call, good luck
Satisfaction Guaranteed
Satisfaction Guaranteed May 15, 2025 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Company Health is rated as GREAT. Analysts say the price should be around $102.71. But Investing.com is saying that the price should be around $56.93????? What are they using a Dart Board to come up with these prices?
Mohsin Hanif
Mohsin Hanif May 14, 2025 2:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it go up or continue to fall.. what is the best price to buy?
Yutaka Tanaka
Yutaka Tanaka May 12, 2025 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How come MRK can go up under Trump's totally adverse EO to force 80% price reduction?
Yutaka Tanaka
Yutaka Tanaka May 12, 2025 8:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How come MRK can go up under Trump's totally adverse EO to force 80% price reduction?
Yutaka Tanaka
Yutaka Tanaka May 12, 2025 8:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How come MRK can go up under Trump's totally adverse EO to force 80% price reduction?
Yutaka Tanaka
Yutaka Tanaka May 12, 2025 8:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How come MRK can go up under Trump's totally adverse EO to force 80% price reduction?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email